What is Becton, Dickinson and Company's medical — d&a?

Becton, Dickinson and Company (BDX) reported medical — d&a of $348.25M in Q3 2025.

How has Becton, Dickinson and Company's medical — d&a changed year-over-year?

Becton, Dickinson and Company's medical — d&a increased by 14.6% year-over-year, from $304M to $348.25M.

What is the long-term trend for Becton, Dickinson and Company's medical — d&a?

Over 4 years (2021 to 2025), Becton, Dickinson and Company's medical — d&a has grown at a 6.2% compound annual growth rate (CAGR), from $1.1B to $1.39B.

What does medical — d&a mean?

The non-cash expense representing the aging and usage of the medical segment's physical and intangible assets.

Business Segments · D&A

Medical — D&A

Becton, Dickinson and Company Medical — D&A remained flat by 0.0% to $348.25M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $304M to $348.25M. Over 4 years (FY 2021 to FY 2025), Medical — D&A shows an upward trend with a 6.2% CAGR.

Analysis

StatementSegment

CategoryEfficiency

SignalContext dependent

VolatilityStable

First reportedQ1 2016

Last reportedQ4 2025Nov 25, 2025

Rolls up toD&A

How to read this metric

Increasing levels often correlate with higher historical capital investment, while sudden spikes may indicate asset impairment or changes in depreciation schedules.

Detailed definition

This metric reflects the systematic allocation of the cost of tangible and intangible assets over their useful lives wit...

Peer comparison

Standard non-cash expense metric used across all capital-intensive industries to reconcile accounting profit to cash flow.

Metric ID: bdx_segment_medical_depreciation_and_amortization

Historical Data

5 years

	FY'21	FY'22	FY'23	FY'24	FY'25
Value	$1.1B	$1.14B	$1.2B	$1.22B	$1.39B
YoY Change	—	+4.3%	+4.8%	+1.4%	+14.6%

Range$1.1B – $1.39B

CAGR+6.2%

Avg YoY Growth+6.3%

Median YoY Growth+4.5%

Current Streak4+ years growth

Similar Metrics at Other Companies

Ingersoll RandIR View metric

International Flavors & FragrancesIFF View metric

BWX TechnologiesBWXT View metric

NordsonNDSN View metric

IlluminaILMN View metric

Quest DiagnosticsDGX View metric

Frequently Asked Questions

What is Becton, Dickinson and Company's medical — d&a?: Becton, Dickinson and Company (BDX) reported medical — d&a of $348.25M in Q3 2025.
How has Becton, Dickinson and Company's medical — d&a changed year-over-year?: Becton, Dickinson and Company's medical — d&a increased by 14.6% year-over-year, from $304M to $348.25M.
What is the long-term trend for Becton, Dickinson and Company's medical — d&a?: Over 4 years (2021 to 2025), Becton, Dickinson and Company's medical — d&a has grown at a 6.2% compound annual growth rate (CAGR), from $1.1B to $1.39B.
What does medical — d&a mean?: The non-cash expense representing the aging and usage of the medical segment's physical and intangible assets.